Allergy Diagnostics Market is Projected To Be Worth US$3.8 Bn By 2024

1
Product - Assay Kits, Consumables,
and Instruments Allergen Type - Inhaled
Allergens, Food Allergens, and Drug Allergens
Test Type - In-vivo and In-vitro tests End Users
- Hospitals, Diagnostic Laboratories, and
Academic Research InstitutesForecast From 2016
- 2024
Allergy Diagnostics Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Market Dynamics
Chapter 6 Allergy Diagnostics Market Analysis, by Product Type
Chapter 7 Allergy Diagnostics Market Analysis, by Allergen Type
Chapter 8 Allergy Diagnostics Market Analysis, by Tests
Chapter 9 Allergy Diagnostics Market Analysis, by End Users
Chapter 10 Allergy Diagnostics Market Analysis, by Region
Chapter 11 North America Allergy Diagnostics Market Analysis
Chapter 12 Europe Allergy Diagnostics Market Analysis
Chapter 13 Asia Pacific Allergy Diagnostics Market Analysis
Chapter 14 Latin America Allergy Diagnostics Market Analysis
Chapter 15 Middle East Africa Allergy Diagnostics Market Analysis
3
Allergy Diagnostics Market Snapshot

• Allergy is a condition when our any of our body
  response adversely to certain products or
  substances. There are various types of allergies,
  such as skin allergy, dust allergy, food allergy
  pollen allergy, etc. In some cases these
  allergies are mild and hence does not cause any
  harm to our body but in certain cases they can be
  fatal if left untreated.
• Rise in prevalence of allergies owing to changes
  in weather condition due to increase in global
  warming is a primary factor expected to boost the
  global allergy diagnostics market.
• Leading players engaged in the allergy
  diagnostics market across the globe are Omega
  Diagnostics Group Plc., Quest Diagnostics Inc.,
  Stallergenes Greer,  BioMerieux and Thermo Fisher
  Scientific Inc

4
(No Transcript)
5
Reports Highlights

• Global allergy diagnostics is expected to rise at
  a healthy CAGR of 12.80 percent during the
  forcast period 2016 to 2024. The market is
  projected to reach a value of US3.8 bn by
  2024-end.
• Growth in technologies dealing with the
  diagnostics of the allergy is another strong
  factor to boost the global allergy diagnostics
  market.

Request Sample
6
Continue..

• In September, 2017, Amgen Inc. And ALLERGAN
  Collectively Obtained FDA Approval For The Use Of
  MVASI To Treat Five Types Of Cancer.
• Continuous Launch Of New Products And Increase In
  The Number Of Patients In Developed And
  Developing Countries.
• Expansion Of Drugs Delivery System Portfolio By
  Improving Existing Drug Delivery Devices And
  Developing And Launching Of New Drug Delivery
  System Through Collaboration.

Request Brochure
7
(No Transcript)